Leaflet GLIMAL 3mg tablets


Indicated for: type 2 diabetes mellitus

Substance: glimepiride (sulfonylurea antidiabetic)

ATC: A10BB12 (Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas)

Glimepiride is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin and improving the sensitivity of cells to insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glimepiride is effective in preventing diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLIMAL 3mg

  • Substance: glimepiride
  • Date of last drug list: 01-07-2013
  • Commercial code: W53465005
  • Concentration: 3mg
  • Pharmaceutical form: tablets
  • Quantity: 60
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for glimepiride

  • 1mg
  • 2mg
  • 3mg
  • 4mg
  • 6mg